Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Nautilus Biotechnology, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 McIlwain Matthew S (Director) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 45,000 options to buy @ $3.97, valued at $178.7k
06/16/2023 4 Posard Matthew L. (Director) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 45,000 options to buy @ $3.97, valued at $178.7k
06/16/2023 4 Pande Vijay Satyanand (Director) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 45,000 options to buy @ $3.97, valued at $178.7k
06/16/2023 4 Epperly Melissa B, (Director) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 45,000 options to buy @ $3.97, valued at $178.7k
06/16/2023 4 NAZEM FARZAD (Director) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 45,000 options to buy @ $3.97, valued at $178.7k
06/16/2023 4 Akinsanya Karen (Director) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 45,000 options to buy @ $3.97, valued at $178.7k
03/01/2023 4 Patel Sujal M (CEO, President, and Secretary) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 650,000 options to buy @ $2, valued at $1.3M
03/01/2023 4 Mowry Anna (CFO and Treasurer) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 160,000 options to buy @ $2, valued at $320k
03/01/2023 4 Murphy Matthew B. (General Counsel) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 160,000 options to buy @ $2, valued at $320k
03/01/2023 4 Godwin Mary E. (Senior VP, Operations) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 160,000 options to buy @ $2, valued at $320k
03/01/2023 4 Mallick Parag (Chief Scientist) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 280,000 options to buy @ $2, valued at $560k
03/01/2023 4 Weld Gwen E (Chief People Officer) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 160,000 options to buy @ $2, valued at $320k
03/01/2023 4 Nelson Nicholas A. (CBO & Senior VP, Bus. Dev.) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 160,000 options to buy @ $2, valued at $320k
03/01/2023 4 Sankar Subramanian (Senior VP, Product Development) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 160,000 options to buy @ $2, valued at $320k
09/28/2022 4 Sankar Subramanian (Senior VP, Product Development) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Bought 10,000 shares @ $2.025, valued at $20.3k
Bought 5,000 shares @ $2.0298, valued at $10.1k
09/26/2022 4 Weld Gwen E (Chief People Officer) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Bought 30,000 shares @ $2.0255, valued at $60.8k
09/19/2022 4 Sankar Subramanian (Senior VP, Product Development) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Bought 40,000 shares @ $2.1938, valued at $87.8k
Bought 35,000 shares @ $2.1556, valued at $75.4k
08/22/2022 4 Mowry Anna (CFO and Treasurer) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Bought 17,500 shares @ $2.2982, valued at $40.2k
08/16/2022 4 Murphy Matthew B. (General Counsel) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Bought 2,500 shares @ $2.85, valued at $7.1k
Bought 7,500 shares @ $2.841, valued at $21.3k
08/08/2022 4 Patel Sujal M (CEO, President, and Secretary) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Bought 41,654 shares @ $2.9204, valued at $121.6k
Bought 8,346 shares @ $2.9288, valued at $24.4k
08/03/2022 4 Godwin Mary E. (Senior VP, Operations) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 30,000 options to buy @ $2.83, valued at $84.9k
07/01/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/28/2022 4 Mowry Anna (CFO and Treasurer) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Bought 5,500 shares @ $2.7499, valued at $15.1k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 NAZEM FARZAD (Director) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 86,467 options to buy @ $2.7, valued at $233.5k
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Pande Vijay Satyanand (Director) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 86,467 options to buy @ $2.7, valued at $233.5k
05/13/2022 4 Murphy Matthew B. (General Counsel) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 10,000 shares @ $3.28, valued at $32.8k
05/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy